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The Bureau of Personnel Services,
formerly the Bureau of Employment
Agencies, was established within the
Department of Consumer Affairs to reg-
ulate those businesses which secure
employment or engagements for others
for a fee. The Bureau regulates both
employment agencies and nurses' regis-
tries. Those businesses which place
applicants in temporary positions or
positions which command annual gross
salaries in excess of $25,000 are exempt
from Bureau regulation.
The Bureau's primary objective is to
limit abuses among those firms which
place individuals in a variety of employ-
ment positions. It prepares and adminis-
ters a licensing examination and issues
several types of licenses upofi fulfillment
of the Bureau's requirements. There are
approximately 2,100 licensees.
The Bureau is assisted by an Advisory
Board created by the Employment
Agency Act. This seven-member Board
consists of three representatives from the
employment agency industry and four
public members. All members are
appointed for a term of four years.
MAJOR PROJECTS:
The Future of the Bureau. With the
passage of Assembly Bill 2929 (Chapter
912, Statutes of 1986), the Bureau of
Personnel Services is, as one member put
it, "at a crossroads." AB 2929, effective
July 1, 1987, redefines the term "em-
ployment agency" to include only agen-
cies which exact or attempt to collect
fees from the applicant for employment.
Thus, "employer-retained" licensees,
which collect only employer-paid fees,
will be excluded from the statute's cov-
erage and the Bureau's regulation as of
July 1.
While this deregulation has caused the
Advisory Board to give serious consider-
ation to the current mission of the
Bureau, several types of agencies are still
regulated by the Bureau under the
Employment Agency Act, including
general employment agencies, nurses'
registries, domestic agencies, prepaid
computer employment agencies, career
counseling services, and job listing servi-
ces. As reported at the Bureau's last
meeting, the Department of Consumer
Affairs (DCA) has considered registering
rather than licensing employment agen-
cies. Computerized registration has been
suggested. Bureau staff plans to meet
with the DCAk to discuss the future of
the Bureau.
RECENT MEETINGS:
AB 2929 and its ramifications were the
main topics of discussion at the Advisory
Board's October 3 meeting in San Fran-
cisco. Because there was no quorum, the
Board met only as a committee.
In addition to discussing the Bureau's
mission, the Board also discussed activi-
ty of temporary agencies. Board member
Howard Rudiger, in his presentation on
"The Mission of the Bureau," contended
that temporary agencies and job fair
organizers are placing more people in
permanent positions than all of the regu-
lated agencies combined and should be
regulated. Members of the nurses' regis-
try industry who were present agreed
with Mr. Rudiger that such unlicensed
activity should be investigated; and that
agencies placing people in permanent
positions should be required to pay
licensing fees.
Rudiger also argued that if the Bureau
is not permitted and funded to license
these agencies which are currently
excluded from the Employment Agency
Act, then perhaps, although he does not
favor such an extreme action, the Bureau
should be sunsetted on an "all or none"
principle.
With reference to funding, Bureau
Chief Jean Orr clarified that the $100
increase (from $200 to $300) in the regis-
tration fee for an initial employment
agency license effective April 1, 1987 is
unrelated to the deregulation of
mployer-retained agencies. The increase
was based upon a recommendation of
the budget analyst made before AB 2929
was passed.
In addition to the problem with tem-
porary agencies, the Board also
discussed the activity of job listing servi-
ces. Such services must be licensed, and
abuse to consumers has recently been
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The Board of Pharmacy grants
licenses and permits to pharmacists,
pharmacies, drug manufacturers, whole-
salers and sellers of hypodermic needles.
It regulates all sales of dangerous drugs,
controlled substances and poisons. To
enforce its regulations, the Board
employs full-time inspectors who inves-
tigate accusations and complaints
received by the Board. Investigations
may be conducted openly or covertly as
the situation demands.
The Board conducts fact-finding and
disciplinary hearings and is authorized
by law to suspend or revoke licenses or
permits for a variety of reasons, includ-
ing professional misconduct and any acts
substantially related to the practice of
pharmacy.
The Board consists of ten members,
three of whom are public. The remaining
members are pharmacists, five of whom
must be active practitioners. All are
appointed for four-year terms.
MAJOR PROJECTS:
Regulations. The Board has proposed
two new sections for addition to Chapter
17 of Title 16 of the California Adminis-
trative Code (CAC). New section 1781.5
will exempt from licensure any drug
wholesaler or manufacturer of hemodi-
alysis drugs whose qualifying supervisory
personnel have (a) passed a written
examination given by the Board; (b)
become licensed pharmacists in a state
other than California; and (c) two or
more years of applicable experience in
the manufacture, compounding, or dis-
tribution of dangerous drugs. The addi-
tion of this proposed section provides
clear guidance as to the qualifications
necessary for exemption certification, by
establishing in regulatory form stand-
ards long used by the Board's staff in
determining exemption requests. The
staff now receives numerous inquiries
about exemption certificate require-
ments, due primarily to the lack of
information in the current regulations.
New section 1781.6 addresses exemp-
tee examinations. The written examina-
tion described in section 1781.5 shall
cover applicable federal and state
statutes and regulations governing the
manufacture, compounding and whole-
sale distribution of dangerous drugs and
devices. To pass the examination, the
qualifying person must achieve a score of
75% or more.
The Board conducted a public hearing
on these proposed new sections on Janu-
ary 29 in Newport Beach.
RECENT MEETINGS:
At the Board's October meeting in Los
Angeles, a fee bill proposal was dis-
cussed. The purpose of the bill is to
charge fees for various certifications and
licenses within the pharmacy field, as
well as to raise the ceiling on the maxi-
mum amount the Board may charge
pharmacists when they acquire licenses.
The California Regulatory Law Reporter Vol. 7, No. 1 (Winter 1987
REGULATORY AGENCY ACTION 61
Since 1981, the Board has proposed two
fee bills. In March 1986, the Board
raised license fees to the maximum level
set by the fee bill currently in effect. The
proposed fee bill, which will be submit-
ted to the legislature in 1987, also
charges fees for the transfer of intern
hours and for licensing of pharmacists
from other states.
Sections 1751-1751.9 in Chapter 17 of
Title 16 of the CAC have now been
approved by the Office of Administra-
tive Law (OAL) and were implemented
on November 6. The regulations, which
were previously disapproved by OAL,
deal with the dispensation of parenteral
drugs. (See CRLR Vol. 6, No. 4 (Fall
1986) p. 49 for details.) The continuing
education regulations, sections 1732.1,
1732.2(c) and (d), in Chapter 17 of Title
16 have been submitted to OAL for
approval.
A task force has been formed to
develop standards for mail order pre-
scriptions. This is a new area for phar-
macists in California and study is needed
to determine what regulations should
govern to protect consumers.
Discussion was resumed regarding the
challenged practices of Travenol, a com-
pany which supplies materials to another
pharmacy which compounds parenteral
solutions, labels them, and returns the
medications to Travenol. Travenol then
delivers the drugs to patients through its
home health care services. If, through
this practice, Travenol is "manufactur-
ing" or "dispensing" drugs, Travenol
may be in violation of the Federal Drug
Act; further, to the extent that these
actions constitute contracting with a
second licensed pharmacy to prepare or
compound medication, they may also
violate the pharmacy law and the Health
and Safety Code of California.
Travenol proposed that the Board
revise and amend section 4046 (c)(l) of
the Business and Professions Code and
section 1717(e) of the CAC to include
language which would be consistent with
the interests of the patient and still allow
Travenol to provide materials to a
pharmacy which will compound the
drugs and return them to Travenol for
delivery to the consumer. The Board has
maintained a neutral position on this
prospective legislation and has decided
to look at the manner in which the fed-
eral Food and Drug Administation
(FDA) handles similar cases. The Board
announced it will invite a spokesperson
from the FDA to a 1987 Board meeting
to update the Board on the FDA's
treatment of this issue.
Another issue which evoked lengthy
discussion was a proposal which would
would allow trained ancillary personnel
to perform certain duties which have
traditionally been performed only by a
licensed pharmacist. The Board dis-
cussed several professional responsibili-
ties which it believes ancillary personnel
should not perform, such as receipt of a
verbal prescription from a physician;
consultation with the patient regarding
medications; initial interpretation of
the prescription; determination of the
product or the generic equivalent
required; final check of the filled pre-
scription; dispensation of appropriate
instructions for patient use; signing
documents requiring the pharmacist's
signature or initials; and providing pro-
fessional consultation to the patient or to
other health care professionals.
The Ad Hoc Committee on Ancillary
Personnel, which had been established to
investigate this matter more fully,
recommended that the use of ancillary
personnel in an expanded role should be
initiated on a trial basis at acute health
care facilities. This suggestion raised
some debate about the political ramifica-
tions of such a selective process of intro-
duction of the new program. Because the
Ad Hoc Committee contained a phar-
macist from an acute care facility but no
pharmacist from a retail pharmacy, it
was suggested that the Committee had
not fairly represented retail pharmacists.
It is believed that this program will
enable a pharmacy to increase its pres-
cription-filling capacity significantly
in a short period of time, and allowing
a limited group of pharmacies to use
ancillary personnel earlier than other
pharmacies in the community could con-
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The Polygraph Examiners Board, an
agency within the Department of Con-
sumer Affairs, regulates the activities of
an estimated 1,000 polygraph examiners
in California. (See Business and Profes-
sions Code sections 9300 et seq.) Cur-
rently, approximately 655 polygraph
examiners are licensed by the Board.
Federally-employed examiners are spe-
cifically excluded from the Board's
jurisdiction.
The Board, which has a January 1, 1989
sunset date, consists of two industry
representatives and three public mem-
bers, all appointed to four-year terms.
MAJOR PROJECTS:
Complaint Tracking System. Staff has
completed a computerized complaint
tracking system which, in response to a
specific inquiry, provides information on
the type of complaint involved, the pres-
ent status of the complaint, and the
actions pending. The system operates on
in-house computers and was developed
by the staff at no extra cost.
Accreditation. The following schools
have been accredited: Keeler Polygraph
School, Military Police School in Fort
Gordon, National Training Center of Lie
Detection, Reid College of Detection
and Deception, and the Zonn Institute.
Adopted Regulations. The Office
of Administrative Law (OAL) has
approved section 3480 of the Board's
regulations at Title 16 of the California
Administrative Code. The new regula-
tion enumerates eight types of conduct
which constitute grounds for disciplinary
action. OAL also approved several other
regulatory changes, including section
3420, which requires applicants to apply
on or before the final filing date
announced for each examination; and
section 3426, which sets forth circum-
stances under which applicants who hold
licenses as polygraph examiners in other
states may be licensed as general poly-
graph examiners without taking the
licensing examination.
RECENT MEETINGS:
At the Board's October meeting in San
Jose, the enforcement committee re-
ported that five investigations are pend-
ing; further, the Riverside District
Attorney's Office is prosecuting an
unlicensed activity case.
The July/August Combined Budget
and Expenditures Statement indicates
that the Board has spent $12,060, leaving
a balance of $87,783.
Staff recommended and the Board
approved the following schools' courses
for accreditation: the American Associa-
tion of Police Polygraphist's May 1986
seminar; and the California Academy of
Polygraph Science's October 1986
seminar and its "Nonverbal Behavior of
the Interviewer Interrogation" seminar.
The Board also discussed a recent
claim that voice stress analyzers have
published advertisements which imply
that their techniques are actually poly-
graphs. Voice stress analysis analyzes
voice pitches and patterns; whereas
polygraph tests measure a person's other
bodily reactions such as pulse and per-
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